Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
27.3M
-
Shares change
-
+8.3M
-
Total reported value, excl. options
-
$667M
-
Value change
-
+$200M
-
Put/Call ratio
-
1.1
-
Number of buys
-
76
-
Number of sells
-
-21
-
Price
-
$24.62
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q3 2016
113 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q3 2016.
Evolent Health, Inc. - Class A Common Stock (EVH) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.3M shares
of 112M outstanding shares and own 24.47% of the company stock.
Largest 10 shareholders include FMR LLC (2.47M shares), JPMORGAN CHASE & CO (2.14M shares), Pennant Capital Management, LLC (2.1M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.7M shares), VANGUARD GROUP INC (1.66M shares), Capital World Investors (1.37M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.35M shares), TimesSquare Capital Management, LLC (1.09M shares), PEREGRINE CAPITAL MANAGEMENT LLC (1.07M shares), and NEXT CENTURY GROWTH INVESTORS LLC (703K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.